EUVIMEDEUVIMED entdecken
KohortenstudieOpen Access · CC BY 4.0

Birth and first-year outcomes in infants of mothers with familial hypercholesterolemia or atherosclerotic cardiovascular disease in the US: A retrospective cohort study

Xinyue Liu, Michelle Fanous, Manish Ponda, Wenqin Qiang, Liang Ni, Alexander Breskin, Xiaoran Yang, Isha M Riley, Caitlin Knox

Journal of Clinical Lipidology · 2026-09 · 20 (9) · 1827-1839

DOI: 10.1016/j.jacl.2026.07.032 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift Journal of Clinical Lipidology, 2026-09. Verfasst von Xinyue Liu und 8 weiteren Autor:innen. Beteiligte Einrichtung: Regeneron Pharmaceuticals Inc, Tarrytown, New York, NY, USA (Liu, Fanous, Ponda, Qiang, Ni, Breskin, Riley, and Knox). Electronic address: xinyue.liu…. Hauptthemen laut MEDLINE: Hyperlipoproteinemia Type II, Atherosclerosis, Mothers. Die Arbeit nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Regeneron Pharmaceuticals Inc.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Infant outcomes among those born to mothers with familial hypercholesterolemia (FH) or atherosclerotic cardiovascular disease (ASCVD) remain unclear. OBJECTIVE: To assess outcomes among infants of mothers living with FH or ASCVD in the US. METHODS: In this retrospective claims-based cohort study, mother-infant singleton pairs (2018-2023) were identified. Infants were followed to death, disenrollment, age 1 year, or the end of 2024. Exposure was classified as maternal prepregnancy diagnosis of FH or ASCVD. Outcomes included preterm birth, low birth weight, macrosomia, neonatal intensive care unit (NICU) admission, major congenital malformations (MCM), infant mortality, and healthcare utilization at 1 year of age. Inverse probability treatment weighting was utilized to compare the FH and ASCVD cohorts with a reference cohort, respectively. RESULTS: Among 275 FH, 878 ASCVD, and 348,683 reference mother-infant pairs, the use of maternal lipid-lowering therapies was rare and declined during pregnancy. No increased risks of adverse outcomes were observed for the FH cohort vs the reference cohort. In contrast, the ASCVD cohort had higher risks of preterm birth (adjusted risk ratio, 1.73 [95% CI, 1.40-2.12]), low birth weight (1.77 [1.28-2.46]), NICU admission (1.48 [1.23-1.77]), and noncardiac MCM (1.58 [1.05-2.37]) than the reference cohort. At 1 year of age, the ASCVD cohort also had higher risks of inpatient admissions, emergency department visits, and urgent care clinic visits. CONCLUSION: Infants of mothers living with ASCVD-but not those with FH-had higher risks of adverse birth outcomes and increased healthcare utilization.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hyperlipoproteinemia Type IIAtherosclerosisMothersHumansFemaleRetrospective StudiesPregnancyAdultInfant, NewbornUnited StatesInfantPregnancy OutcomeMalePremature Birth

Stichwörter der Autor:innen

Atherosclerotic cardiovascular diseaseBirth outcomesFamilial hypercholesterolemiaInfant outcomesPregnancy

Autor:innen und Institutionen

  • Regeneron Pharmaceuticals Inc, Tarrytown, New York, NY, USA (Liu, Fanous, Ponda, Qiang, Ni, Breskin, Riley, and Knox). Electronic address: xinyue.liu@regeneron.com.
  • Regeneron Pharmaceuticals Inc, Tarrytown, New York, NY, USA (Liu, Fanous, Ponda, Qiang, Ni, Breskin, Riley, and Knox).
  • University of Southern California, Los Angeles, CA, USA (Yang).

Förderung

  • Regeneron Pharmaceuticals Inc

Zitieren

APA

Liu, X., Fanous, M., Ponda, M., Qiang, W., Ni, L., Breskin, A., Yang, X., Riley, I. M., & Knox, C. (2026). Birth and first-year outcomes in infants of mothers with familial hypercholesterolemia or atherosclerotic cardiovascular disease in the US: A retrospective cohort study. Journal of Clinical Lipidology, 20(9), 1827-1839. https://doi.org/10.1016/j.jacl.2026.07.032

Vancouver

Liu X, Fanous M, Ponda M, Qiang W, Ni L, Breskin A, et al. Birth and first-year outcomes in infants of mothers with familial hypercholesterolemia or atherosclerotic cardiovascular disease in the US: A retrospective cohort study. Journal of Clinical Lipidology. 2026;20(9):1827-1839. doi:10.1016/j.jacl.2026.07.032

BibTeX
@article{Liu2026,
  author = {Liu, Xinyue and Fanous, Michelle and Ponda, Manish and Qiang, Wenqin and Ni, Liang and Breskin, Alexander and Yang, Xiaoran and Riley, Isha M and Knox, Caitlin},
  title = {Birth and first-year outcomes in infants of mothers with familial hypercholesterolemia or atherosclerotic cardiovascular disease in the US: A retrospective cohort study},
  journal = {Journal of Clinical Lipidology},
  year = {2026},
  volume = {20},
  number = {9},
  pages = {1827--1839},
  doi = {10.1016/j.jacl.2026.07.032}
}
Kostenlos starten →